Innate Pharma SA has applied for an initial public offering and listing on the Euronext in Paris, to raise funds to expand its pipeline of oncology therapeutics.

AstraZeneca’s outrageously high bid for Cambridge Antibody Technology underscores the heat rising in the biotech market.

French and Belgian researchers have genetically modified strains of the bacteria as treatments for human gastrointestinal disorderse – and are keen to form licensing and partnering deals to take this research forward.

Israel researchers have developed a drug testing system that allows “human” trials to be carried out on laboratory animals. They are now opening talks with pharmaceutical companies .

While US companies have halted research into plant-made pharmaceuticals - or even gone bust - European companies are pressing ahead

The European Union's plan to transform Europe's drug discovery industry borrows some of its style from the US - but not everything.

Chroma Therapeutics Ltd raised £30 million in a third private round, giving the chromatin specialist funding for the next three years and enabling it to advance the lead programme through Phase II clinical studies and bring two further products into the clinic.

How do you take a pill before you wake up? Denmark's Egalet has found an answer, and is looking for partners to help develop it.

After the initial hype, the long haul through clinical development and the inevitable pitfalls, gene therapy is on the verge of becoming a commercial reality in Europe - ahead of the US.